INTERSTITIAL LUNG DISEASE DUE TO CONNECTIVE TISSUE DISEASE (DISORDER)
Clinical trials for INTERSTITIAL LUNG DISEASE DUE TO CONNECTIVE TISSUE DISEASE (DISORDER) explained in plain language.
Never miss a new study
Get alerted when new INTERSTITIAL LUNG DISEASE DUE TO CONNECTIVE TISSUE DISEASE (DISORDER) trials appear
Sign up with your email to follow new studies for INTERSTITIAL LUNG DISEASE DUE TO CONNECTIVE TISSUE DISEASE (DISORDER), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug aims to shield lungs during cancer radiation
Disease control Recruiting nowThis study is testing whether a drug called BIO 300 can help protect the lungs of patients who have both early-stage lung cancer and a separate lung scarring disease (interstitial lung disease) when they receive radiation therapy. The main goal is to see if BIO 300 can prevent se…
Matched conditions: INTERSTITIAL LUNG DISEASE DUE TO CONNECTIVE TISSUE DISEASE (DISORDER)
Phase: PHASE2 • Sponsor: Memorial Sloan Kettering Cancer Center • Aim: Disease control
Last updated Mar 27, 2026 12:38 UTC
-
One-Stop hospital visit could slash hours of waiting for lung patients
Disease control Recruiting nowThis study is testing a new, more efficient way for patients with chronic lung scarring diseases (like pulmonary fibrosis) to attend their regular hospital check-ups. Currently, these visits can be spread over multiple days, requiring separate trips for tests and doctor appointme…
Matched conditions: INTERSTITIAL LUNG DISEASE DUE TO CONNECTIVE TISSUE DISEASE (DISORDER)
Phase: NA • Sponsor: Hospital de Granollers • Aim: Disease control
Last updated Mar 23, 2026 15:15 UTC
-
New study aims to slash wait times for serious lung disease diagnosis
Diagnosis Recruiting nowThis study is testing whether a more organized and faster diagnostic process can reduce the time it takes for patients to get a clear diagnosis for suspected interstitial lung disease (ILD). It will compare the current standard, often fragmented process to a new, coordinated appr…
Matched conditions: INTERSTITIAL LUNG DISEASE DUE TO CONNECTIVE TISSUE DISEASE (DISORDER)
Phase: NA • Sponsor: Hospital de Granollers • Aim: Diagnosis
Last updated Apr 01, 2026 14:41 UTC